Xin Cai

机构：First Affiliated Hospital of Zhengzhou University

发表论文 63 篇 · 总被引 1022 次 · h-index 17

代表论文

• Current Progress and Future Perspectives of Immune Checkpoint in Cancer and Infectious Diseases (2021 · Frontiers in Genetics · 被引 69)
• Pembrolizumab in Chinese patients with advanced melanoma: 3-year follow-up of the KEYNOTE-151 study (2022 · Frontiers in Immunology · 被引 29)
• Carbon ion radiotherapy with pencil beam scanning for hepatocellular carcinoma: Long‐term outcomes from a phase I trial (2022 · Cancer Science · 被引 18)
• Discovery of a Novel and Potent Cyclin-Dependent Kinase 8/19 (CDK8/19) Inhibitor for the Treatment of Cancer (2024 · Journal of Medicinal Chemistry · 被引 14)
• Design, Synthesis, and Biological Evaluation of Novel Orally Available Covalent CDK12/13 Dual Inhibitors for the Treatment of Tumors (2025 · Journal of Medicinal Chemistry · 被引 13)
• Exploratory Evaluation of Personalized Ultrafractionated Stereotactic Adaptive Radiation Therapy (PULSAR) With Central Nervous System-Active Drugs in Brain Metastases Treatment (2024 · International Journal of Radiation Oncology*Biology*Physics · 被引 11)